ArticleCancer medicine2024

Efficacy and safety of atezolizumab plus bevacizumab in patients with portal hypertension for unresectable hepatocellular carcinoma.

Takahiro Kinami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.